Sivik Global Healthcare’s Puma Biotechnology PBYI Stock Holding History

Sivik Global Healthcare’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-40,000	Closed	-$1.55M	–	66
2019 Q1	$1.55M	Buy	+40,000	New	+$1.22M	0.57%	55
2018 Q3	–	Sell	-20,000	Closed	-$1.18M	–	67
2018 Q2	$1.18M	Sell	20,000 -5,000	-20%	-$290K	0.45%	58
2018 Q1	$1.7M	Sell	25,000 -10,000	-29%	-$749K	0.79%	53
2017 Q4	$3.46M	Buy	35,000 +15,000	+75%	+$1.68M	1.29%	35
2017 Q3	$2.4M	Hold	20,000	–	–	0.82%	48
2017 Q2	$1.75M	Sell	20,000 -10,000	-33%	-$559K	0.64%	54
2017 Q1	$1.12M	Hold	30,000	–	–	0.52%	55
2016 Q4	$921K	Buy	+30,000	New	+$1.3M	0.44%	51

Other funds holding PBYI

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Macquarie Group

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return